Trial intelligence / Profile preview

Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes with DME

NCT04089605Phase 4Completed

Sponsor
Far Eastern Memorial Hospital
Start
Jun 2017
Primary completion
Nov 2018
Modality
Implantable Devices, Implantable Hydrogels, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ozurdex in diabetic macular edema (DME), sponsored by Far Eastern Memorial Hospital. Started Jun 2017; status: completed.

02

Drugs

ozurdex
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT04089605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04089605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call